Literature DB >> 23711084

Attention-deficit/hyperactivity disorder, physical health, and lifestyle in older adults.

Evert J Semeijn1,2, J J Sandra Kooij2, Hannie C Comijs1, Marieke Michielsen1,2, Dorly J H Deeg1,3, Aartjan T F Beekman1.   

Abstract

OBJECTIVES: To increase insight into the effect of attention-deficit/hyperactivity disorder (ADHD) on health in general in older adults.
DESIGN: Two-phase sampling side-study.
SETTING: Longitudinal Aging Study Amsterdam (LASA). PARTICIPANTS: Two hundred twenty-three randomly selected LASA respondents. MEASUREMENTS: Information was collected during home visits on physical health, medication use, and lifestyle characteristics in Phase 1 and on ADHD diagnosis in Phase 2. The associations between independent variables and ADHD were examined with linear and logistic regression analyses.
RESULTS: The adjusted regression estimates of the linear regression analysis showed that the number of ADHD symptoms was positively associated with the presence of chronic nonspecific lung diseases (CNSLD) (B = 2.58, P = .02), cardiovascular diseases (B = 2.18, P = .02), and number of chronic diseases (B = 0.69, P = .04) and negatively associated with self-perceived health (B = -2.83, P = .002). Lifestyle is not a mediator of the association between ADHD and physical health.
CONCLUSION: Attention-deficit/hyperactivity disorder in older adults was associated with chronic physical illness and poorer self-perceived health. Contrary to expectations, there were no associations between symptoms of ADHD and lifestyle variables.
© 2013, Copyright the Authors Journal compilation © 2013, The American Geriatrics Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23711084     DOI: 10.1111/jgs.12261

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   7.538


  7 in total

1.  Exposure-response analyses of blood pressure and heart rate changes for methylphenidate in healthy adults.

Authors:  Liang Li; Yaning Wang; Ramana S Uppoor; Mehul U Mehta; Tiffany Farchione; Mitchell V Mathis; Hao Zhu
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-18       Impact factor: 2.745

2.  Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study.

Authors:  Lin Li; Zheng Chang; Jiangwei Sun; Miguel Garcia-Argibay; Ebba Du Rietz; Maja Dobrosavljevic; Isabell Brikell; Tomas Jernberg; Marco Solmi; Samuele Cortese; Henrik Larsson
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

3.  Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult ADHD Outpatients.

Authors:  Giulia di Girolamo; Irene Francesca Bracco; Alberto Portigliatti Pomeri; Soraya Puglisi; Francesco Oliva
Journal:  Front Psychiatry       Date:  2022-06-21       Impact factor: 5.435

Review 4.  Clinical Presentation, Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Older Adults: A Review of the Evidence and its Implications for Clinical Care.

Authors:  David W Goodman; Sara Mitchell; Lauren Rhodewalt; Craig B H Surman
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

5.  Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review.

Authors:  Johanne Telnes Instanes; Kari Klungsøyr; Anne Halmøy; Ole Bernt Fasmer; Jan Haavik
Journal:  J Atten Disord       Date:  2016-09-01       Impact factor: 3.256

6.  The Longitudinal Aging Study Amsterdam: cohort update 2016 and major findings.

Authors:  Emiel O Hoogendijk; Dorly J H Deeg; Jan Poppelaars; Marleen van der Horst; Marjolein I Broese van Groenou; Hannie C Comijs; H Roeline W Pasman; Natasja M van Schoor; Bianca Suanet; Fleur Thomése; Theo G van Tilburg; Marjolein Visser; Martijn Huisman
Journal:  Eur J Epidemiol       Date:  2016-08-20       Impact factor: 8.082

7.  ADHD and lifestyle habits in Czech adults, a national sample.

Authors:  Simon Weissenberger; Radek Ptacek; Martina Vnukova; Jiri Raboch; Martina Klicperova-Baker; Lucie Domkarova; Michal Goetz
Journal:  Neuropsychiatr Dis Treat       Date:  2018-01-15       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.